To further investigate the impact of blockade of NHE1 function in immunogenicity in glioma tumors, we conducted immunostaining assay for CD8+ T cells to evaluate immune cell infiltration in the tumor. This evidence concerns the gene SLC9A1 and central nervous system cancer.